Dupont Capital Management Corp Exelixis, Inc. Transaction History

Dupont Capital Management Corp

$1.18 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	SELL	$16.3 - $19.41 $149,666 - $178,222	-9,182 Reduced 54.96%	7,525 $146,000
Q4 2022 Jan 26, 2023	SELL	$14.96 - $17.39 $35,844 - $41,666	-2,396 Reduced 12.54%	16,707 $0
Q3 2022 Oct 31, 2022	SELL	$15.68 - $22.27 $29,164 - $41,422	-1,860 Reduced 8.87%	19,103 $300,000
Q2 2022 Jul 26, 2022	SELL	$17.44 - $23.16 $157,291 - $208,880	-9,019 Reduced 30.08%	20,963 $436,000
Q1 2022 Apr 27, 2022	BUY	$17.03 - $22.67 $249,063 - $331,548	14,625 Added 95.23%	29,982 $680,000
Q4 2021 Jan 31, 2022	SELL	$15.84 - $21.88 $231,707 - $320,060	-14,628 Reduced 48.78%	15,357 $281,000
Q3 2021 Nov 03, 2021	SELL	$16.3 - $21.14 $19,054 - $24,712	-1,169 Reduced 3.75%	29,985 $634,000
Q2 2021 Jul 30, 2021	SELL	$17.95 - $25.56 $39,723 - $56,564	-2,213 Reduced 6.63%	31,154 $568,000
Q1 2021 Apr 29, 2021	BUY	$20.53 - $25.22 $150,710 - $185,140	7,341 Added 28.21%	33,367 $754,000
Q4 2020 Jan 28, 2021	SELL	$18.39 - $24.8 $5,185 - $6,993	-282 Reduced 1.07%	26,026 $522,000
Q3 2020 Oct 29, 2020	SELL	$20.67 - $26.94 $251,781 - $328,156	-12,181 Reduced 31.65%	26,308 $643,000
Q2 2020 Jul 24, 2020	SELL	$16.46 - $27.42 $260,611 - $434,140	-15,833 Reduced 29.15%	38,489 $914,000
Q1 2020 Apr 29, 2020	SELL	$14.46 - $21.8 $406,456 - $612,776	-28,109 Reduced 34.1%	54,322 $935,000
Q4 2019 Jan 27, 2020	BUY	$15.15 - $18.89 $55,403 - $69,080	3,657 Added 4.64%	82,431 $1.45 Million
Q3 2019 Oct 28, 2019	SELL	$17.68 - $22.65 $450,557 - $577,212	-25,484 Reduced 24.44%	78,774 $1.39 Million
Q2 2019 Jul 30, 2019	BUY	$18.93 - $24.75 $1.03 Million - $1.35 Million	54,655 Added 110.18%	104,258 $2.23 Million
Q1 2019 Apr 30, 2019	BUY	$19.6 - $24.76 $539,058 - $680,974	27,503 Added 124.45%	49,603 $1.18 Million
Q4 2018 Feb 01, 2019	BUY	$13.65 - $21.8 $5,460 - $8,720	400 Added 1.84%	22,100 $435,000
Q3 2018 Nov 05, 2018	BUY	$15.87 - $22.4 $280,533 - $395,964	17,677 Added 439.4%	21,700 $385,000
Q2 2018 Jul 30, 2018	SELL	$18.56 - $22.45 $9,131 - $11,045	-492 Reduced 10.9%	4,023 $87,000
Q1 2018 May 02, 2018	SELL	$22.15 - $31.89 $546,041 - $786,152	-24,652 Reduced 84.52%	4,515 $100,000
Q3 2017 Oct 31, 2017	BUY	$23.35 - $29.24 $681,049 - $852,843	29,167	29,167 $707,000

Others Institutions Holding EXEL

# of Institutions

501

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.19 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.04 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$905 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$547 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$408 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Account